Refine
Year of publication
- 2019 (91) (remove)
Document Type
- Conference Proceeding (91) (remove)
Keywords
- Enterprise Architecture (2)
- Aircraft design (1)
- Case Study (1)
- Change Management (1)
- Corporate Culture (1)
- Correlations (1)
- Design rules (1)
- Digital Age (1)
- Digitalisierung (1)
- Diversity Management (1)
- Drag (1)
- Earthquake (1)
- Engineering (1)
- Force (1)
- Geometry (1)
- Geschäftsmodell (1)
- Graph Theory (1)
- Green aircraft (1)
- Hybrid-electric aircraft (1)
- In-plane (1)
Institute
- Fachbereich Luft- und Raumfahrttechnik (25)
- Fachbereich Elektrotechnik und Informationstechnik (24)
- Fachbereich Maschinenbau und Mechatronik (12)
- IfB - Institut für Bioengineering (12)
- Fachbereich Medizintechnik und Technomathematik (11)
- Fachbereich Energietechnik (8)
- MASKOR Institut für Mobile Autonome Systeme und Kognitive Robotik (7)
- Fachbereich Bauingenieurwesen (5)
- Solar-Institut Jülich (5)
- Fachbereich Wirtschaftswissenschaften (4)
- ECSM European Center for Sustainable Mobility (2)
- Fachbereich Chemie und Biotechnologie (2)
The discovery of human induced pluripotent stem cells reprogrammed from somatic cells [1] and their ability to differentiate into cardiomyocytes (hiPSC-CMs) has provided a robust platform for drug screening [2]. Drug screenings are essential in the development of new components, particularly for evaluating the potential of drugs to induce life-threatening pro-arrhythmias. Between 1988 and 2009, 14 drugs have been removed from the market for this reason [3]. The microelectrode array (MEA) technique is a robust tool for drug screening as it detects the field potentials (FPs) for the entire cell culture. Furthermore, the propagation of the field potential can be examined on an electrode basis. To analyze MEA measurements in detail, we have developed an open-source tool.